Petróleo Brasileiro S.A. - Petrobras (PBR)
Buenos Aires Exchange · Argentina · prices in ARS · close of 22 Oct 2026
Key indicators
| Last close | ARS 41,900.00 |
|---|---|
| 52-week range | 16,160.00 – 42,500.00 |
| Return, 1 month / 3 months | +26.3% / +44.8% |
| Return, 1 year / 3 years | +141.0% / – |
| Trend | Uptrend |
| RSI (14) | 73 |
| Volatility (1 year) | 35.5% |
| Worst drawdown (1 year) | -22.8% |
| Average daily value traded | 1,990.15M ARS |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Petróleo Brasileiro S.A., known as Petrobras, is an integrated energy company based in Brazil. It explores for and produces crude oil and natural gas, with much of its output coming from deep-water offshore fields. The company also operates refineries that turn crude into fuels and other petroleum products, and it distributes and markets these products to customers in Brazil and other countries. Its activities span the whole chain from finding oil to delivering refined fuels.
Petróleo Brasileiro S.A. - Petrobras trades under the code PBR on the Buenos Aires Exchange in Argentina, with its price quoted in Argentine pesos (ARS). Our dividend records, which start in 2019, show payments in 2 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Petróleo Brasileiro S.A. - Petrobras (PBR) trades on the Buenos Aires Exchange in Argentina. It last closed at ARS 41,900.00 on 22 October 2026.
Its price-based Market X-Ray is 84 out of 100 (a strong price profile), ranking 2 of 154 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 141.0% and over the last three months it rose 44.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Buenos Aires Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 92 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 51.5% | ||
| From 52-week high | -0.6% | ||
| Momentum | 92 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 44.8% | ||
| 6-month return | 42.1% | ||
| 12-month return, skipping the last month | 90.9% | ||
| Stability (higher is calmer) | 66 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 35.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -22.8% | ||
| Liquidity | 88 · Strong | Trades actively. | |
| Average daily value traded | 1,990.15M ARS | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +2.6% |
|---|---|
| 1 month | +26.3% |
| 3 months | +44.8% |
| 6 months | +42.1% |
| 1 year | +141.0% |
| 3 years | – |
| 5 years | – |
Signals
| 50-day / 200-day average | 34,106.12 / 27,661.31 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1,090.71 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 25 Aug 2026 | BRL 804.0550 |
| 3 Jun 2026 | BRL 430.4845 |
| 24 Apr 2026 | BRL 363.5934 |
| 26 Dec 2025 | BRL 512.3826 |
| 25 Aug 2025 | BRL 359.5594 |
| 4 Jun 2025 | BRL 425.7396 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Buenos Aires Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.